When a blockbuster product went off patent at one of the world’s top pharmaceutical organizations, the company’s marketing team turned to IMS to help them gain market share with new products in new therapeutic classes. In a case study, IMS’s Nina Felton describes how our consultants were able to refocus the client on the right prescribers, the right messages, the right frequency and the right channels, so that far fewer promotional dollars generated greater results. IMS Promo.Mix™, a consulting offering that determines the optimal mix of promotional efforts to drive brand performance, was used to address this client’s needs. 

IMS Promo.Mix is one of the IMS Promo.360™ suite of offerings that’s making its mark on the pharma industry.